|
|
|
| calgb.org > CALGB Web Site Home |
|
| Welcome to the Cancer and Leukemia Group B |
 The Cancer and Leukemia Group B (CALGB) is a national clinical research group sponsored by the National Cancer Institute, with the Central Office headquartered at the University of Chicago and Statistical Center located at Duke University. Founded in 1956, the CALGB brings together clinical oncologists and laboratory investigators to develop better treatments for cancer. CALGB has grown exponentially over the years into a national network of 26 university medical centers, more than 200 community hospitals and more than 3,000 oncology specialists who collaborate in clinical research studies. These studies aim to reduce morbidity and mortality from cancer, relate biological characteristics of cancer to clinical outcomes, and develop new strategies for the early detection and prevention of cancer.
[About CALGB]
|
| CALGB News |
|
|
| CALGB Foundation |
The Cancer and Leukemia Group B Foundation is a nonprofit, tax-exempt foundation that helps the Cancer and Leukemia Group B (CALGB) answer important treatment questions through large-scale clinical trials. Through efforts of the CALGB Foundation in support of CALGB clinical trials and laboratory research, donors can help find new ways to prevent, treat and cure many types of cancer, including leukemia and lymphoma, and cancers of the breast, prostate, lung and GI tract, and help educate the medical community on methods of cancer diagnosis, treatment and prevention.
Here are some recent initiatives supported by the CALGB Foundation:
- New chemotherapy treatments for breast, prostate, lung and colorectal cancer.
- New surgical techniques for breast and colon cancer.
- Genetic studies of breast cancer risk.
- Molecular determinants of response to therapy for breast, colorectal and lung cancers, and leukemia.
- Research that improves the quality of life for cancer patients and their caregivers.
|
|
|
|
|
